| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 307.96M | — |
| Operating expense | — | — |
| Net income | 31.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACAD returned +14.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +10.4% |
| 1 year | +14.6% |
| 5 years | +68.5% |
| 10 years | -8.2% |
| All-time high | $56.66 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ACAD would be worth today ›No. ACADIA Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
ACADIA Pharmaceuticals Inc. stock trades on NASDAQ under the ticker symbol ACAD.
ACADIA Pharmaceuticals Inc. is part of the Healthcare sector.
ACADIA Pharmaceuticals Inc. has a market cap of 5.08B USD, based on the latest quote.
ACADIA Pharmaceuticals Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
